michigan semaglutide bowel obstruction law firm Ozempic and Wegovy are marketed as a short-term holy grail for weight loss by some startups. Doctors disagree The FDA sent a warning

In a Phase II study reported in 2024 involving 168 patients with NASH, moderate to advanced fibrosis (F2F3), and NAS 4, a significantly greater proportion of patients in the denifanstat group achieved the primary endpoint compared with placebo, with statistically meaningful improvements in fibrosis as well

High risk and low prevalence diseases: metformin toxicities

AKI, acute kidney injury

Microdosing GLP-1s Cheat Sheet: Key Differences to Know If you are looking for the bottom line on how microdosing compares to standard care, this breakdown shows the trade-offs clearly

If additional glycemic control is needed after at least four weeks, the dose may be increased to 1 mg once weekly , and subsequently to a maximum of 2 mg once weekly